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Abstract
Sexual side dficts ofpsychiatric medications have been estimated to occur in 60% ofmale
clients (1) and 30%offemale clients (2). Despite a bodyofliterature relating individual medications
to specific sexual side dficts, fe to studies have satisfactorily addressed the psychotropic-induced
sexual dysfunctions in women. The spectrum ofknoton sexual sidedficts resultingfrompsychophar-
macologic interventions will be reviewed. GuidelinesJOr appropriately addressing the possibility qf
sexual side effects within a therapeutic relationship.for maximizing reporting ofsexual side dficts,
andfor possible treatment approaches to sexual sidedficts will be described.
INTRODUCTION
The pa st twenty years have shown a dramat ic su rge in the a pproaches to and
tools of bio logical psychi atry. Concomitant with th ese adva nces has eme rge d aware-
ness of psychotropic-induced se xua l side effec ts. These side effec ts may con tribu te to
physiological morbidity, to e mba rrassme n t and sh ame, to non complian ce, to stress-
induced sym ptom exace rba tion, and, argu ably, to mistrust of psychi at ric pr actit io-
ners . Represen ta t ives of severa l classes of psychiatric medi cations- including bcn zo-
diaz epines, beta-blockers, lit hi um, monoamine oxidase inhibitors, neu rol ep t ics, and
tri- and tetra-cyclic a nt ide pressa n ts- ha ve been report ed to ca use so me form of
se xua l impairment.
Kn own sexua l side effec ts associated with psych otropi cs include anorgasmia (3) ,
un satisfyin g or painful or gasm (4), a lte re d libid o or sex ua l willing ness, erecti le
fa ilu re, priapi sm (5), menstrual irregul ariti es, delayed or ret rograd e ejacula t ion (6) ,
a nd a lte red sexual se nsa tion and se ns itivity (7,8) . Yet , th e se xual side effects of
psych o-pharmaceuticals are st ill a mo ng th e most subt le, least discu ssed , and poorly
understood conseq ue nce s of modern medi cal treatments.
The psychiatric lit erature contains numerous case reports but few well -designed
research stud ies addressing sexual side effec ts (9). This knowl ed ge ga p may reflect
wides pread erotophobic attitudes, skewed funding a nd ed uca t ional prio r it ies around
th e importan ce of human se xuality, or inad equa te training of pr escribers in eliciting
sexua l side effec ts from clients.
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In add it ion, very few of th e ex ist ing stud ies include fe male subjects (10 ,11,1 2);
those that do oft en fail to separat e outcomes by ge nde r, rendering problematic th e
drawing of conclus ions relevant to wom en clients. The lack of a tt en tion to incid en ces
a nd expe riences of psych otropi c-gen erat ed sexual side effec ts in wom en may occur
for several reason s. First , th e ease of measureme nt of ma le se xua l arousal (e rec tio n)
an d orgas m (ejacula t ion) , a nd th e rela tive simplicity of male e ndoc rine fun ction s,
may have con t r ibu ted to a researc h bias towa rd male subjects, Second, th e sexual
emo tions, respon ses, a nd beh aviors of wome n a re fre q ue n t ly constrained by cult ur ally-
based and se xist cr ite r ia; th e sa me cult ura l se xism may reduce t he mo tivation for th e
com pre he ns ive examina t ion of th e pot ential ac tio ns of psychiatric medication s on
femal e sex ua lity. (T his hypothesis is so mewha t suppor te d by the dearth of publish ed
information on ge neral fema le sexua l funct ion) .
Third , th e na rrow definiti on s of fe male sexual dysfunction may result in
incon sist ent re po rt ing or inap propriat e dat a analysis . For example, qu eryin g lesbi a n
clients abo ut int ercourse may be irrelevant ; not qu eryi ng wom en specificall y abou t
fant asy, a bou t lubrication, abo ut ejacula t ion, or abo ut th e size , shape , sens itivity, and
se nsa tion of br east s, vagina, and clitoris may lead to om ission of vit al informa t ion.
Finally, th e subjectivity inh erent in t he determi na tion and describing of sex ua l
impai r ment may lead to varia tions between studies, introducing difficulty in com pil-
ing dat a: there is a d iffere nce bet wee n libido and orgasm. Nevertheless, th e available
reports do sugges t so me ge neral patt erns of sexual sid e effec ts, in wom en , from
psych ot ropics.
SUMMARY OF PSYCH OTROPI C-IND UCED SEXUAL DYSFUNCTIO NS IN WO~IEN
In fema le pat ients, several psychopharmacologic agents have been implicat ed as
causative of sexual side effects. Alprazolam (13), amoxapine (14) , clomipram ine
(15,16, 17), dia zepa m ( 18), fluphenazine ( 19), flurazepam (20) , imipramine (21,22),
MAGIs (2 1,23,24,25,26), thiorid azin e (27) , a nd t rifluoroperazine (27) hav e all been
spec ifica lly rep ort ed to inhibit orgas m . Fenflu ra mine has been repor ted to enha nce
orgasm (28).
Howeve r, th e story is not so st raightforward. Desip ra mine has been rep ort ed to
ca use anorgasmia (29) and not to cause anorgasmia (22) . Fluox etine has been
reported to in hib it orgasm (30,3 1,26) and to e nha nce orgasm (32) . Simila rly,
t razod one has been re ported to inc rease (33) and decrease (34) libido.
PERSPECTI VES ON PHARMACOSEXO LOGY
T he rela t ionship betwee n psychiatric medi cations and resultant se xua l dysfunc-
tion is complex. Animal models suggest that sexual fun ction is dep endent upon
ce n t rally-act ing dopa mi ne agonis ts and is inhibi ted by th e se ro tone rgic syste m (35).
In hu man males, decr eases in libido have been attributed to anti-dopam inergic
and se ro to nergic effec ts (36), as well as to limbic fluctua tion s and to decreased levels
of endoge no us opioids and test ost erone (37). Hu ma n male erec tion, medi at ed
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principally by autonomic neurons, may be diminish ed: a ) by interferen ce with central
dopaminergic output (38) ; b) by int erferen ce with bet a-adren ergic ac t ivity or by
enha nce me nt of a lphaj -ad rc ne rg ic transmission (39); c) by int erferen ce with th e
choline rg ic spinal reflex es necessary for erect io n; or d) by int errupt ion of th e
neuronal-hematological fillin g of the co rpora.
Human male ejacula t ion, m ediat ed by alpha I-ad re ne rg ic receptors, may be
a n tagonized by alpha I-ad re ne rgic blo ckade. Human mal e orgas m [which is no t
neces sarily identical with ej ac u la tion], thought to be ce nt ra l in or igin, may be
e lim ina te d by serotonergic age nts (40). Cl early, th e se ro to ne rg ic agon ism, th e
dopaminergic a nd cholinergic blo ckade, and alpha I-ad re ne rg ic effec ts res ult ing from
some psychiat ric medications might aIte r sexual function in ma le clients (41) .
Though anatomic analogies m ay be made between male a nd fe male libido,
between male erection and female lubrication /labi al swelling , between m ale ejacula-
tion and female ejaculation , and between male and female orgasm , th e neu rophysiol-
ogy of femal e sexuality-animal or human-is less com ple te ly understood th an the
male counterpart. Conclusions about effe cts, on wom en , of a n t i-do pam ine rgic ,
a n t i-a lpha r-ad re nc rgic, anticholinergic, and serotonergic effec ts remain th eoret ica l
a nd sp eculative.
CLINICAL DISCUSSION AND GUIDELINES
Psychotropic-induced sexual sid e effec ts may be ameli orat ed with bioch em icall y-
informed interventions. Neverthel ess, ad equat e identification and treat ment of
psychotropi c-induced se x ua l side effec ts require a n inform ed , di scerning, and sensi-
tive psychiatric practitioner, since m any patients will not spo ntaneously rep or t such
co nce rns. What follow a re some sugges t ions for a ppro pr ia te ly add ressing th e possibil-
ity of se x ua l sid e effec ts within a th erapeutic rel ation ship, for max imi zing report ing
of se xua l sid e effec ts, and for a ppro ac hing treatment of se xual side effec ts.
When a patient expe rie nces a se xual dysfuncti on relat ed to a psychiatric
m edication , the initial priority is to det ermine wh ether th e dysfunct ion is me d ication-
induced. This may be done, with some ce rtain ty, by retracing sym p to m developm ent
in relation to m edication dosing , in the abse nce of ot he r prescribed or ove r- the-
cou n te r medications and in th e absence of co ncom itan t emot iona l st ress. If an
e t iologica l con nect ion between psychiatric m edication a nd se xua l side effec t appears
likely, then the next st ep is to as sess the ex te nt of di scomfort expe rie nce d by the
patient, since the patient who is substantially bothered by th e dysfuncti on will
participate most cooperatively in treating th e sid e effec t. The sim ples t trea tm en t
approach to psychotropic-induced se xua l sid e effec ts is to make only a psych ological
intervention. In cert ain inst ances, suc h an ac t ion might be indicat ed ; anorgasmia
induced by MAGIs has been report ed to remit naturall y (42) . An add it iona l psycho-
logical intervention mi ght be referral to cou ples or individual se x therapy or
psychotherapy, wh en relevant. However, se xual side effec ts must be monit ored , and
this minimalistic strat egy must be full y ex pla ine d to th e client.
Another approach might be to reduce the dose of th e puta t ively offending
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psychiatric medi cation . If dose re d uc t ion fails to allevia te th e sexual symptom s, or if
th e primary psychiatric sym ptoms return, th en th e clinician might consider drug
substitu t ion from a different che mica l class.
Combination th erap y, with two psych ot ropi c agen ts be lieved to produce an tago-
nistic sex ual side effec ts, might minimize the sexual side effect of eac h while
maximizin g th e syne rg istic psych iatric effect. For instance , th e coupling oftrazod one-
which has been rep orted to increase libido in wome n-and fluoxetine-which has
been reported to decrease libido in women-might prove useful.
The se lec t ive utilization of psych opharmacolo gic agents not associated with
se xual dysfuncti on may reduce th e incid ence of suc h ia trogenic morbidit y. Specifi-
ca lly, no publish ed report exis ts , as of this wr it ing, link ing buproprion or bu spi ron e
wit h sex ual side effects . In fact, busp iron e has been reported to reverse ge ne ra lized
sexual dysfun cti on related to a nxie ty (43).
Prescription of a medi cation used in treat ment of endogenous sexu al dysfun c-
tion mi ght ass ist in returning th e patien t 's sex ual funct ion to baseline. Yohimbine
(44), naltrexon e, a nd apomorphine ca n each alleged ly elicit penile erec tions (45); it is
unknown what influence th ey would exer t up on wome n.
Addition of a second me d ica tion, aimed a t addressing th e psych otropic-induced
sex ual dysfun ct ion, may have benefit. Seve ral reports have implied that libid o has
been enhanced by the cho line rgic agen t betha nechol (46,47) and by th e dopamine
agonist bromocrip ti ne (48) . Several mixed-gender reports have sugges ted tha t
a no rgasmia induced by MAGIs (49), fluoxet in e (50), a nd m ulticyclic antidepressants
(29,26,5 1) migh t be reduced by th e se ro to nin an tagonist cyproheptadine. How ever, it
is importan t to keep in mind that , j ust as primary psychiatric medications ca n elicit
sid e effects, so can adjunct ive medications. Cyproheptadine has been associated wit h
anticho linergic crisis in conjunction with treatment of t ricyclic-induced ano rgasmia
(29) .
A helpful ove rarc hing stra tegy is to develop a solid, mutually trusting clini cal
re lat ions hip with each pa ti ent a nd to ro u t ine ly obtain a com plet e sexua l history
before prescribing a ny psych ot ropi c me dica tions. Not only does t he sexual informa-
t ion gathered es tablish a baseline against which to detect future cha nges in th e
patient 's sexua l fun ction, bu t direct ly bringing th e client 's sexual histo ry into th e
patient-practit ioner in teraction also increases the likel ihood th at th e client will fee l
welcomed to discuss subjectively perceived changes in sexual fun cti on whic h may
ar ise. As king about specific practices, abou t partners and relationships, and ab out th e
importance of sexua lity in t he client's overall funct ioning will be more useful than
simply querying broad ly about sexua l orientation, partnership st atus, age a t pubert y,
or history of orgasm.
Practitioners' com for t di scussing issues of client sexuality, practit ion ers' sexual
knowledge, and practitioners' sex-positive attitudes are a ll responsibl e for obtaining
thorough sexual histories a nd for eliciting, following up on , a nd for ed uca ting abou t
psychotropic-ind uce d sexual side effects. Sex-positive at titudes will a lso permit
clinic ian- researc he rs to add to psychi a t ry 's un derstan d ing of the possible insidi ou s
outcomes of prescr ibed med ica t ions. In the long run, psychiatric clients will ben efit
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directly from sex-positive attitudes , from op enness to a nd em pathy toward clients'
sexual conce rn s, and from application of the mo st co m ple te ava ilable dat a about
sexual side effec ts .
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